No Anti-Viral Treatment for COVID-19

gparkof1 Covid 19, Covid II

There is no specific antiviral treatment recommended for COVID-19,

 

Generally clinical facilities and private doctors follow the protocol of treatment as dictated by the NIH and CDC in the United States and in Israel by the Health Ministry. Doctors are understandably reluctant to use untried treatments and regimens outside of the standard procedures.  Dr Vladimir Zelenko in Kiryas Yoel, New York (near Monsey) took matters into his own hands when he saw the seriousness of the Covid-19 Virus Pandemic. He investigated and found that South Korea was successfully giving their patients a combination of hydroxychloroquine and Zinc. He also saw that in France they were giving patients hydroxychloroquine and azithromycin, an antibiotic, again with some success. Dr. Zelenko combined these two approaches and the end results of his efforts as outlined below were extremely successful. He defined success in this way: 1) A patient does not die. 2)The patient stays off the respirator 3) the patient stays out of the hospital (which means he goes home after his doctor visit.)

Dr. Zelenko made a decision not to wait until experimental drugs and procedures are approved by the CDC, NIH, and FDA in a  process that could take three months to six months to a year,  He clearly understood that if a patient’s mild to serious symptoms turned catastrophic, they would have a low chance of survival, especially in the hospital  He also noted that people who go on a respirator (especially over 60 or who are already compromised in some way) have a 60% chance of dying. Dr.Zelenko’s techniques are being  used by many other doctors in United States and abroad once he was able to publicize his procedures and success rate. By contrast, here is the response of the NIH to the Covid-19 Pandemic crisis.

Treatment / Management  NIH Website

There is no specific antiviral treatment recommended for COVID-19, and no vaccine is currently available. The treatment is symptomatic, and oxygen therapy represents the major treatment intervention for patients with severe infection. Mechanical ventilation may be necessary in cases of respiratory failure refractory to oxygen therapy, whereas hemodynamic support is essential for managing septic shock. 

On January 28, 2020, the WHO released a document summarizing WHO guidelines and scientific evidence derived from the treatment of previous epidemics from HCoVs. This document addresses measures for recognizing and sorting patients with severe acute respiratory disease; strategies for infection prevention and control; early supportive therapy and monitoring; a guideline for laboratory diagnosis; management of respiratory failure and ARDS; management of septic shock; prevention of complications; treatments; and considerations for pregnant patients.

Among these recommendations, we report the strategies for addressing respiratory failure, including protective mechanical ventilation and high-flow nasal oxygen (HFNO) or non-invasive ventilation (NIV).

https://www.ncbi.nlm.nih.gov/books/NBK554776/

There are a lot of words on NIH posts – but after a quick search this was the clearest statement I could find. It is distressing because I have documented from the internet and the news at least four doctors that are using a protocol –  which seems to work – These doctors can be seen at this website: (and each of these doctors have a network of associate doctors who are following similar procedures.

https://hardball.parkoffletter.org/

 Dr. Sehault and Dr. Sayed explain the science and reasoning for their prophylactic protocol – and cite numerous scientific studies supporting their conclusions. They are research professionals attached to the Stanford University Medical School.   Dr. Zelenko seems to have been silenced by a comedy of errors and the threat of a Federal Investigation – the story is in the New York Times attached as a PDF to this e-mail.

Dr. Zelenko relates that out of a population of 450 patients whom he treated initially without any tests confirming the presence of the Covid Virus – but with the symptoms -eleven went to the hospital , of which two died. The remainder of the patients were treated with the drug cocktail for 5 days and went home –  Dr. Zelenko  sent his statistics and results  to the FDA and other medical authorities – including the heads of various medical schools.

He is also in touch with Mark Meadows Chief of Staff in the White House and Stephen Hahn – head of the FDA.

Here are Dr. Zelenko’s statistics: (In Dr. Zelenko’s words)

  • 1450 patients with the Covid 19 Virus.
  • Divide this into two groups, high risk and low risk.
  • High risk means a 5% chance of death.
  • This group is treated with the triple medical cocktail,
  • hydroxychloroquine, 200 mg twice a day for five days
  • Azithromycin, 500 mg once a day for five days
  • Zinc Sulfate, 220 milligrams once a day for five days.
  • 405 people treated
  • two died in the hospital
  • four were on a respirator who came off the respirator and doing better
  • five people in the hospital with pneumonia receiving IV Antibiotics and doing better.
  • If you assume a 5% mortality, should have seen 20 people dead and at least 40 on a respirator.
  • Several orders of magnitude difference -reduction of death by  95%
  • The key thing  is to initiate treatment immediately based on clinical suspicion even before confirmatory testing because thee is a very narrow window of time to intervene to clear the virus before it becomes uncontrollable.

GP: It is upsetting that  when there are successful treatments for seriously ill people, that they are not used because of the lack of official approval.  Clearly success is not a standard of measurement unless the conclusions for treatment are drawn from a Double Blind Random Study, which means a placebo is administered to half of the group under study and both the  Researchers and the Patients do not know who is getting the placebo. This is the Gold Standard for establishing medical procedures in the clinic or doctor’s office. They take a very long time to be completed.

When Dr Zelenko had to decide who was a high-risk patient out of a total client population of 1050, he cited age, Diabetes, Cancer, and being overweight as key factors in being selected for treatment. .  These are standard measures in much of the literature on  Covid-19.